Shan-Yu Su

Dr. Shan-Yu Su

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2010 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
CCChin-Yi Cheng
Chin-Yi Cheng
SSShan-Yu Su
Shan-Yu Su
NTNou-Ying Tang
Nou-Ying Tang
THTin-Yun Ho
Tin-Yun Ho
WLWan-Yu Lo
Wan-Yu Lo
CHChing-Liang Hsieh
Ching-Liang Hsieh

7 March 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CCChin-Yi Cheng
Chin-Yi Cheng
JLJaung-Geng Lin
Jaung-Geng Lin
SSShan-Yu Su
Shan-Yu Su
NTNou Ying Tang
Nou Ying Tang
SKShung-Te Kao
Shung-Te Kao
CHChing-Liang Hsieh
Ching-Liang Hsieh
Background: This study was designed to evaluate the effects of electroacupuncture-like stimulation at Baihui (GV20) and Dazhui (GV14) acupoints (EA at acupoints) following mild cerebral ischemia-reperfusion (I/R) injury. Furthermore, we investigated whether brain-derived neurotrophic factor (BDNF)-mediated activation of extracellular signal-regulated kinase (ERK)1/2 signaling pathway is involved in the neuroprotection induced by EA at acupoints. Methods: Rats were subjected to middle cerebral artery occlusion (MCAo) for 15 min followed by reperfusion for 3 d. EA at acupoints was applied 1 d postreperfusion then once daily for 2 consecutive days. Results: Following the application of EA at acupoints, initiated 1 d postreperfusion, we observed significant reductions in the cerebral infarct area, neurological deficit scores, active caspase-3 protein expression, and apoptosis in the ischemic cortex after 3 d of reperfusion. We also observed markedly upregulated BDNF, phospho-Raf-1 (pRaf-1), phospho-MEK1/2 (pMEK1/2), phospho-ERK1/2 (pERK1/2), phospho-90 kDa ribosomal S6 kinase (pp90RSK), and phospho-Bad (pBad) expression, and restored neuronal nuclear antigen (NeuN) expression. Pretreatment with the MEK1/2 inhibitor U0126 abrogated the effects of EA at acupoints on cerebral infarct size, neurological deficits, active caspase-3 protein, and apoptosis in the ischemic cortex after 3 d of reperfusion. Pretreatment with U0126 also abrogated the effects of EA at acupoints on pMEK1/2, pERK1/2, pp90RSK, pBad, and NeuN expression, but did not influence BDNF and pRaf-1 expression. Conclusion: Overall, our study results indicated that EA at acupoints, initiated 1 d postreperfusion, upregulates BDNF expression to provide BDNF-mediated neuroprotection against caspase-3-dependent neuronal apoptosis through activation of the Raf-1/MEK1/2/ERK1/2/p90RSK/Bad signaling cascade after 3 d of reperfusion in mild MCAo.

1 January 2009 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
CHChing-Liang Hsieh
Ching-Liang Hsieh
THTin-Yun Ho
Tin-Yun Ho
SSShan-Yu Su
Shan-Yu Su
WLWan-Yu Lo
Wan-Yu Lo
CLChung-Hsiang Liu
Chung-Hsiang Liu
NTNou-Ying Tang
Nou-Ying Tang

15 December 2010 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JTJung-Ying Tsao
Jung-Ying Tsao
HTHsieh-Ho Tsai
Hsieh-Ho Tsai
CWChien-Pang Wu
Chien-Pang Wu
PLPi-Yun Lin
Pi-Yun Lin
SSShan-Yu Su
Shan-Yu Su
YTYuhsin Tsai
Yuhsin Tsai

1 January 2010 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
NTNou-Ying Tang
Nou-Ying Tang
CLChung-Hsiang Liu
Chung-Hsiang Liu
SSShan-Yu Su
Shan-Yu Su
YJYa-Min Jan
Ya-Min Jan
CHChing-Tou Hsieh
Ching-Tou Hsieh
CHChing-Liang Hsieh
Ching-Liang Hsieh

1 August 2014 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
SSShan-Yu Su
Shan-Yu Su
CMChih-Hsin Muo
Chih-Hsin Muo
FSFung-Chang Sung
Fung-Chang Sung
DMDonald E. Morisky
Donald E. Morisky